Congenital Clubfoot as an Early Manifestation of Duchenne Muscular Dystrophy? [PDF]
Kenis V +4 more
europepmc +1 more source
Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber +4 more
wiley +1 more source
Erratum: Microdystrophins partially rescue deficits of Duchenne muscular dystrophy iPSC-cardiomyocytes. [PDF]
Keegan AR +14 more
europepmc +1 more source
Dynamic changes in total hemoglobin concentration in the frontal region during motion-based video gameplay in patients with Duchenne muscular dystrophy: a pilot study using portable near-infrared spectroscopy (NIRS). [PDF]
Okano S, Mori S, Nishizawa H.
europepmc +1 more source
Functional assessments used in routine care for duchenne muscular dystrophy in the United States: A survey of certified duchenne care centers. [PDF]
Duvuru R +8 more
europepmc +1 more source
Influence of community disadvantage on cognitive performance in son-mother dyads in Duchenne muscular dystrophy. [PDF]
Karra H +7 more
europepmc +1 more source
Role of Finerenone in Duchenne Muscular Dystrophy in a 45-Year-Old Man: Outcome and Brief Review. [PDF]
Hillyer J, Jefferies JL, Silver MA.
europepmc +1 more source
Development and Validation of a Novel, Disease-Specific, Caregiver-Reported Outcome Measure: The Duchenne Muscular Dystrophy Caregiver Reported-Health Index (DMDCR-HI). [PDF]
Engebrecht C +11 more
europepmc +1 more source
Basal Energetics and Phosphocreatine Recovery Kinetics in Ambulatory Boys With Duchenne Muscular Dystrophy. [PDF]
Awale PP +5 more
europepmc +1 more source

